We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
  • Patient Resources
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
    • Glossary
  • Professional Resources
    • Research Center Profiles
    • Industry Provider Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
  • About Us
  • Contact Us
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Arthur J. Higgins joins Endo board of directors

Arthur J. Higgins joins Endo board of directors

December 13, 2013
CenterWatch Staff

Arthur J. Higgins has been appointed to Endo Health Solutions’ board of directors. Joseph C. Scodari will retire as a director, effective Dec. 31.

Higgins has over 30 years of domestic and international pharmaceutical industry experience. He currently is a senior advisor to Blackstone Healthcare Partners, the dedicated healthcare team of The Blackstone Group, where he focuses on product-based healthcare acquisitions. Previously, he was chairman of the board of management of Bayer HealthCare and chairman and CEO of Enzon Pharmaceuticals.    

Higgins currently is a senior advisor to Blackstone Healthcare Partners, the dedicated healthcare team of The Blackstone Group, where he focuses on product-based healthcare acquisitions. Previously, Higgins was chairman of the board of management of Bayer HealthCare, a developer and manufacturer of human and animal health products and chairman of the Bayer HealthCare Executive Committee. Higgins was chairman, president and CEO of Enzon Pharmaceuticals from 2001 to 2004. He also spent 14 years with Abbott Laboratories, including as president of the Pharmaceutical Products Division from 1998 to 2001.

Mr. Higgins currently works on the boards of Ecolab, Resverlogix and Zimmer Holdings. He is a past member of the board of directors of the Pharmaceutical Research and Manufacturers of America (PhRMA), of the council of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and president of the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Global News Awards & Advancement

Upcoming Events

  • 16Dec

    Master the Regulatory Pathway for Cell & Gene Therapy Submissions: Strategies for Successful BLAs

Featured Products

  • Regenerative-medicine-steps-to-accelerate-development-pdf

    Regenerative Medicine: Steps to Accelerate Development — PDF

  • Clinical-trial-agreements-a-guide-to-key-words-and-phrases-pdf

    Clinical Trial Agreements: A Guide to Key Words and Phrases — PDF

Featured Stories

  • Ich_logo

    ICH Overhauls 22-Year-Old Clinical Studies Guideline

  • Survey_chart2019

    Sponsors, CROs Doing Better, Sites Say, But More Work Is Needed

  • China-360x240

    U.S. Tops List of Trial Startups With China Making Progress in Phase 1

  • Phoneapp-360x240

    Device Apps Present Unique Risks in Trials

New!

2019 Site Survey Reports

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing